{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-001367","form_type":"8-K","ticker":null,"cik":"0001922858","company_name":"ECD Automotive Design, Inc.","filed_at":"2026-01-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.774751+00:00","generated_at":"2026-05-16T10:13:06.683675+00:00","sec_items":["3.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Nasdaq determines to delist ECD Automotive Design; trading moves to OTC from Jan 16, 2026","bullets":["Nasdaq Hearings Panel denied additional time; delisting of common stock and warrants effective Jan 16, 2026.","Trading on Nasdaq suspended at open on Jan 16; company expects to commence trading on OTC Market the same day.","Company had failed to regain compliance with minimum bid price ($1.00) and $35M market value listing standard.","Prior reverse stock split (1-for-40) and $500M equity line did not cure deficiencies; Panel cited prior split as bar to new compliance period."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-001367","json":"https://secwatch.observer/filing/0001437749-26-001367.json","markdown":"https://secwatch.observer/filing/0001437749-26-001367.md","text":"https://secwatch.observer/filing/0001437749-26-001367.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/0001437749-26-001367-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/ecda20260115c_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:13:06.683675+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8a3ffdf4c435fb8b2cf6e03e72deb25457e5103f","claim":"ECD Automotive Design, Inc. received a nasdaq delisting notice notice regarding market value.","evidence_excerpt":"January 15, 2026, the Company received a letter from the Staff stating that the Panel has determined to delist the Company’s securities, both common stock and warrants, from The Nasdaq Stock Market and that trading in the Company’s securities on The Nasdaq Stock Market will be suspended at the open of trading on January 16, 2026. The Company’s securities are expected to commence trading on the OTC Market commencing on January 16, 2025.","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/0001437749-26-001367-index.htm","confidence":0.85},{"claim_id":"a26f2bd2ecbeec9536b49c2f8d168f7dd1c4c8e7","claim":"ECD Automotive Design, Inc. received a nasdaq delisting notice notice regarding minimum bid price.","evidence_excerpt":"January 15, 2026, the Company received a letter from the Staff stating that the Panel has determined to delist the Company’s securities, both common stock and warrants, from The Nasdaq Stock Market and that trading in the Company’s securities on The Nasdaq Stock Market will be suspended at the open of trading on January 16, 2026. The Company’s securities are expected to commence trading on the OTC Market commencing on January 16, 2025.","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/0001437749-26-001367-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001213900-26-062844","ticker":"ADTX","company_name":"Aditxt, Inc.","filed_at":"2026-05-29T20:21:24+00:00","headline":"Aditxt receives Nasdaq deficiency for negative equity; delisting hearing set for June 11","event_type":"other_material","sec_items":["3.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-062844","json":"https://secwatch.observer/filing/0001213900-26-062844.json","markdown":"https://secwatch.observer/filing/0001213900-26-062844.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/0001213900-26-062844-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/ea0292786-8k_aditxt.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 15, 2026, the Company received a letter from the Staff stating that the Panel has determined to delist the Company’s securities, both common stock and warrants, from The Nasdaq Stock Market and that trading in the Company’s securities on The Nasdaq Stock Market will be suspended at the open of trading on January 16, 2026. The Company’s securities are expected to commence trading on the OTC Market commencing on January 16, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/0001437749-26-001367-index.htm","comparable_excerpt":"May 27, 2026, Aditxt, Inc. (the “Company”)\nreceived a letter (the “Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market\nLLC (“Nasdaq”) notifying the Company that, based on the stockholders’ equity of $(35,174,386) reported in the Company’s\nQuarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company no longer satisfies the minimum\nstockholders’ equity requirement of $2,500,000 for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1)\n(the “Stockholders’ Equity Requirement”). The Letter further","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390026062844/0001213900-26-062844-index.htm"}},{"accession":"0001104659-26-066974","ticker":"LIMN","company_name":"Liminatus Pharma, Inc.","filed_at":"2026-05-27T20:30:41+00:00","headline":"Liminatus Pharma receives Nasdaq delisting notice; appeals filed","event_type":"other_material","sec_items":["3.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-066974","json":"https://secwatch.observer/filing/0001104659-26-066974.json","markdown":"https://secwatch.observer/filing/0001104659-26-066974.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/0001104659-26-066974-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/tm2615785d1_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 15, 2026, the Company received a letter from the Staff stating that the Panel has determined to delist the Company’s securities, both common stock and warrants, from The Nasdaq Stock Market and that trading in the Company’s securities on The Nasdaq Stock Market will be suspended at the open of trading on January 16, 2026. The Company’s securities are expected to commence trading on the OTC Market commencing on January 16, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/0001437749-26-001367-index.htm","comparable_excerpt":"May 20, 2026, the Company received a notice\nfrom Nasdaq stating that the Company had not regained compliance with the MVLS Rule and the MVPHS Rule. Accordingly, its securities will\nbe delisted from The Nasdaq Global Mark","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926066974/0001104659-26-066974-index.htm"}},{"accession":"0001829126-26-005568","ticker":"PMI","company_name":"Picard Medical, Inc.","filed_at":"2026-05-21T20:15:19+00:00","headline":"Picard Medical Q1 revenue up 85% to $1.2M; reports $1.4M negative equity, NYSE listing notices","event_type":"other_material","sec_items":["2.02","3.01","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-005568","json":"https://secwatch.observer/filing/0001829126-26-005568.json","markdown":"https://secwatch.observer/filing/0001829126-26-005568.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626005568/0001829126-26-005568-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626005568/picardmedical_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 15, 2026, the Company received a letter from the Staff stating that the Panel has determined to delist the Company’s securities, both common stock and warrants, from The Nasdaq Stock Market and that trading in the Company’s securities on The Nasdaq Stock Market will be suspended at the open of trading on January 16, 2026. The Company’s securities are expected to commence trading on the OTC Market commencing on January 16, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/0001437749-26-001367-index.htm","comparable_excerpt":"reviously disclosed, on May\n8, 2026, the Company received a notice that it was not in compliance with Section 1003(a)(ii) (the “May 8 Notice,” and together\nwith the May 15 Notice, the “ Notices ”). In connection with the","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626005568/0001829126-26-005568-index.htm"}},{"accession":"0001213900-26-059270","ticker":"XXI","company_name":"Twenty One Capital, Inc.","filed_at":"2026-05-20T12:49:08+00:00","headline":"Tether International acquires SoftBank's stake in Twenty One Capital; board members resign","event_type":"other_material","sec_items":["1.02","3.01","5.02","8.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-059270","json":"https://secwatch.observer/filing/0001213900-26-059270.json","markdown":"https://secwatch.observer/filing/0001213900-26-059270.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2070457/000121390026059270/0001213900-26-059270-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2070457/000121390026059270/ea0291071-8k_twenty.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 15, 2026, the Company received a letter from the Staff stating that the Panel has determined to delist the Company’s securities, both common stock and warrants, from The Nasdaq Stock Market and that trading in the Company’s securities on The Nasdaq Stock Market will be suspended at the open of trading on January 16, 2026. The Company’s securities are expected to commence trading on the OTC Market commencing on January 16, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/0001437749-26-001367-index.htm","comparable_excerpt":"o independent directors, the minimum number required during the transition period\nfor compliance with Section 303A.07(a) of the NYSE Listed Company Manual, as provided in Section 303A.00 of the NYSE Listed Company Manual","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2070457/000121390026059270/0001213900-26-059270-index.htm"}},{"accession":"0001493152-26-023889","ticker":"GCTK","company_name":"Glucotrack, Inc.","filed_at":"2026-05-15T20:45:37+00:00","headline":"Glucotrack receives second Nasdaq delisting notice; plans to appeal by May 18","event_type":"other_material","sec_items":["3.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-023889","json":"https://secwatch.observer/filing/0001493152-26-023889.json","markdown":"https://secwatch.observer/filing/0001493152-26-023889.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226023889/0001493152-26-023889-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226023889/form8-k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 15, 2026, the Company received a letter from the Staff stating that the Panel has determined to delist the Company’s securities, both common stock and warrants, from The Nasdaq Stock Market and that trading in the Company’s securities on The Nasdaq Stock Market will be suspended at the open of trading on January 16, 2026. The Company’s securities are expected to commence trading on the OTC Market commencing on January 16, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/0001437749-26-001367-index.htm","comparable_excerpt":"May 15, 2026, the Company received a second letter from Nasdaq notifying the Company that its Form 10-Q for the period ended March\n31, 2026, indicates that the Company no longer meets the $2,500,000 minimum stockholders’","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1506983/000149315226023889/0001493152-26-023889-index.htm"}},{"accession":"0001437749-26-016455","ticker":"BKYI","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2026-05-12T20:46:03+00:00","headline":"BIO-key receives Nasdaq delisting notice; stock to move to OTC Markets on May 13","event_type":"other_material","sec_items":["3.01","7.01","9.01"],"materiality_score":0.95,"calibrated_materiality_score":0.95,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-016455","json":"https://secwatch.observer/filing/0001437749-26-016455.json","markdown":"https://secwatch.observer/filing/0001437749-26-016455.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/0001437749-26-016455-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/bkyi20260512_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 15, 2026, the Company received a letter from the Staff stating that the Panel has determined to delist the Company’s securities, both common stock and warrants, from The Nasdaq Stock Market and that trading in the Company’s securities on The Nasdaq Stock Market will be suspended at the open of trading on January 16, 2026. The Company’s securities are expected to commence trading on the OTC Market commencing on January 16, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/0001437749-26-001367-index.htm","comparable_excerpt":"May 6, 2026, BIO-key International, Inc. (the “ Company ”) received notice from the staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) stating that the Company had not regained compliance with Nasdaq Listing Rule 5550(a)","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/0001437749-26-016455-index.htm"}},{"accession":"0001829126-26-004960","ticker":"PMI","company_name":"Picard Medical, Inc.","filed_at":"2026-05-11T21:08:14+00:00","headline":"Picard Medical raises $5M in public offering, receives NYSE American delisting notice for low equity","event_type":"other_material","sec_items":["1.01","3.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-004960","json":"https://secwatch.observer/filing/0001829126-26-004960.json","markdown":"https://secwatch.observer/filing/0001829126-26-004960.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/0001829126-26-004960-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/picardmedical_8k.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 15, 2026, the Company received a letter from the Staff stating that the Panel has determined to delist the Company’s securities, both common stock and warrants, from The Nasdaq Stock Market and that trading in the Company’s securities on The Nasdaq Stock Market will be suspended at the open of trading on January 16, 2026. The Company’s securities are expected to commence trading on the OTC Market commencing on January 16, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/0001437749-26-001367-index.htm","comparable_excerpt":"May 8, 2026, the Company received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) requiring a company to have stockholders’ equity of at least $4.0 million if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The Notice states that the Company reported a stockholders’ equity of approximately $3.8 million as of","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2030617/000182912626004960/0001829126-26-004960-index.htm"}},{"accession":"0001749723-26-000045","ticker":"NFE","company_name":"New Fortress Energy Inc.","filed_at":"2026-05-07T23:59:59+00:00","headline":"New Fortress Energy receives Nasdaq delisting notice for bid price below $1.00","event_type":"other_material","sec_items":["3.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: exchange_compliance_notice","same SEC item: 3.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001749723-26-000045","json":"https://secwatch.observer/filing/0001749723-26-000045.json","markdown":"https://secwatch.observer/filing/0001749723-26-000045.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1749723/000174972326000045/0001749723-26-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1749723/000174972326000045/nfe-20260501.htm"},"side_by_side_evidence":{"fact_type":"exchange_compliance_notice","source_excerpt":"January 15, 2026, the Company received a letter from the Staff stating that the Panel has determined to delist the Company’s securities, both common stock and warrants, from The Nasdaq Stock Market and that trading in the Company’s securities on The Nasdaq Stock Market will be suspended at the open of trading on January 16, 2026. The Company’s securities are expected to commence trading on the OTC Market commencing on January 16, 2025.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1922858/000143774926001367/0001437749-26-001367-index.htm","comparable_excerpt":"May 1, 2026, New Fortress Energy Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based on the closi","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1749723/000174972326000045/0001749723-26-000045-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}